Back to Agenda
Panel Discussion
Speaker(s)
Moderator
Markham Luke, MD, PhD
Director for Therapeutic Performance, Office of Generic Drugs, CDER, FDA, United States
Panelists
Charles DiLiberti, MS
President, Montclair Bioequivalence Services, LLC, United States
Panelists
Xiaohui (Jeff) Jiang
Division Deputy Director, Division of Therapeutic Performance, Office of Generic, FDA, United States
Panelists
Darby Kozak, PhD
Lead for Complex Drug Substances and Dosage Forms, OGD, CDER, FDA, United States
Panelists
Andrew A. LeBoeuf, JD, MS
, Neurocrine, United States
Panelists
Sam G. Raney, PhD, MS
Associate Director for Science, ORS, Office of Generic Drugs, CDER, FDA, United States
Have an account?